albendazole has been researched along with Intestinal Diseases, Parasitic in 189 studies
Intestinal Diseases, Parasitic: Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 52 adult patients with opisthorchiasis with or without concomitant intestinal helminthic infections were treated with albendazole at dosage regimens of 400 mg twice daily for 3 days (group I with 25 patients) and 7 days (group II 27 patients)." | 9.05 | Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. ( Bunnag, D; Harinasuta, T; Pungpark, S, 1984) |
| " This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days." | 5.32 | Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004) |
| "A longitudinal study was conducted in Sierra Leone to measure the impact of a single dose anthelminthic (400 mg albendazole) and daily iron-folate supplements (36 g iron and 5 mg folate) on haemoglobin (HG) concentration during pregnancy." | 5.09 | Anthelminthic treatment and haemoglobin concentrations during pregnancy. ( Hodges, M; Torlesse, H, 2000) |
| "A total of 52 adult patients with opisthorchiasis with or without concomitant intestinal helminthic infections were treated with albendazole at dosage regimens of 400 mg twice daily for 3 days (group I with 25 patients) and 7 days (group II 27 patients)." | 5.05 | Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. ( Bunnag, D; Harinasuta, T; Pungpark, S, 1984) |
| " Albendazole can be beneficial for taeniasis and strongyloidiasis." | 4.83 | [Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults]. ( Debonne, JM; Rey, P, 2006) |
| " While undergoing treatment with albendazole, he developed worsening diarrhea with abdominal pain and fever." | 4.79 | Albendazole-induced pseudomembranous colitis. ( Altice, FL; Marino, C; Shah, V, 1996) |
| " The introduction of oxamniquine and praziquantel constitutes a break through in the treatment of intestinal and urogenital schistosomiasis." | 4.76 | [Present status of the treatment of helminthiasis]. ( Coulaud, JP, 1984) |
| "Treatment of severe symptomatic trichuriasis observed with heavy worm burdens is not satisfactory with recommended doses of mebendazole, flubendazole and albendazole." | 4.76 | Benzimidazoles in the treatment of trichuriasis: a review. ( Maisonneuve, H; Rossignol, JF, 1984) |
| "Ivermectin and albendazole are used in annual mass drug administration (MDA) for the lymphatic filariasis elimination programmes in African countries co-endemic for onchocerciasis, but have additional impact on soil transmitted helminths and the ectoparasitic mite which causes scabies." | 3.78 | Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact. ( Deb, RM; Mohammed, KA; Molyneux, DH; Stanton, MC, 2012) |
| " Our case who has rheumatoid arthritis (RA) and bronchial asthma was treated with low dose steroids and methotrexate." | 3.76 | Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. ( Altintop, L; Bektas, A; Cakar, B; Hokelek, M; Karaoglanoglu, M; Yildiz, L, 2010) |
| " This paper examines the actual costs of a combination of mass and selective treatment for schistosomiasis using praziquantel and mass treatment for intestinal nematodes using albendazole, as an integral part of school health programmes reaching 80442 pupils in 577 schools in Volta Region, Ghana, and reaching 109099 pupils in 350 schools in Tanga Region, Tanzania." | 3.70 | The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development. ( , 1999) |
| "We designed a maize (corn) flour fortified with grounded dried papaya (Carica papaya) seeds and used it to prepare porridge as per the usual school meal recipe Children from three primary schools from Nandi County in Kenya were randomized into three arms: One school received 300 ml papaya fortified porridge daily (papaya group), the second school received similar serving of plain porridge without the pawpaw ingredient (control group) and the third school received plain porridge and the conventional MDA approach of one time 400 mg dosage of albendazole (albendazole arm)." | 2.87 | Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey. ( Keter, L; Kinyua, J; Kugo, M; Maina, G; Maiyo, A; Ndemwa, P; Otieno, P; Songok, EM, 2018) |
| "Intestinal nematode infections caused by soil-transmitted helminths (STH), such as the roundworm Ascaris lumbricoides, the whipworm Trichuris trichiura, and the hookworms Ancylostoma duodenale, and Necator americanus, infect more than 1 billion people throughout the world." | 2.82 | Important Nematodes in Children. ( Veesenmeyer, AF, 2022) |
| "HI titers against both influenza A strains as well as memory B-cell response were modestly higher in the antihelminthic treated group compared to the placebo group but the difference was not statistically significant." | 2.80 | Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial. ( Adegnika, AA; Agnandji, ST; Bache, E; Berberich, S; Brückner, S; Engleitner, T; Esen, M; Fernandes, JF; Kremsner, PG; Lell, B; Massinga Loembe, M; Mordmüller, B; Schweiger, B; Yazdanbakhsh, M, 2015) |
| " About a fifth of the children reported adverse events, which were mainly mild." | 2.80 | Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled t ( Albonico, M; Ali, SM; Alles, R; Ame, SM; Bogoch, II; Hattendorf, J; Huwyler, J; Keiser, J; Speich, B; Utzinger, J, 2015) |
| "Albendazole did not cause a change in TST size (P = 0." | 2.75 | Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections. ( Evans, CA; Garcia, HH; Vergara, A; Vergara, KC; Vidal, C; Zevallos, K, 2010) |
| "Helminthiasis is an infestation of the human body with parasitic worms." | 2.72 | Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy. ( Bhutta, ZA; Das, JK; Salam, RA, 2021) |
| " The health workers administered the correct dosage satisfactorily and there were no adverse effects." | 2.71 | Periodic deworming with albendazole and its impact on growth status and diarrhoeal incidence among children in an urban slum of India. ( Bhattacharya, SK; Manna, B; Rajendran, K; Saha, DR; Sur, D, 2005) |
| "Treatment with metronidazole for E." | 2.68 | Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren. ( Furnée, CA; Hautvast, JG; van der Haar, F; West, CE, 1997) |
| "Treatment with albendazole led to clinical responses in six of 10 patients, and dietary manipulation resulted in clinical improvement in eight of nine patients." | 2.39 | Clinical features of microsporidiosis in patients with AIDS. ( Asmuth, DM; DeGirolami, PC; Desai, G; Ezratty, CR; Federman, M; Pleskow, DK; Wanke, CA, 1994) |
| "Sepsis and meningitis are frequent." | 2.38 | [Systemic strongyloidiasis. Review]. ( Chacín-Bonilla, L, 1991) |
| " Sample information was recorded and encompassed trade name, active ingredient name, manufacturer's name and full address, labeled medicine strength, dosage form, number of units per container, dosage statement, batch/lot number, manufacturing and expiry dates, storage information and presence of leaflets/package insert." | 1.48 | Quality of anthelminthic medicines available in Jimma Ethiopia. ( Belew, S; D'Hondt, M; De Spiegeleer, B; Duchateau, L; Kosgei, A; Suleman, S; Wynendaele, E, 2018) |
| "Praziquantel was not available in any of the HF." | 1.48 | Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi. ( Bizimana, P; Muhimpundu, E; Ngenzebuhoro, C; Nsabiyumva, F; Ortu, G; Polman, K; Van Geertruyden, JP, 2018) |
| "Eosinophilia was encountered in 21% of the children." | 1.42 | Prevalence of intestinal helminths, anemia, and malnutrition in Paucartambo, Peru. ( Arque, E; Cabada, MM; Clinton White, A; Deichsel, EL; Goodrich, MR; Graham, B; Lopez, M; Villanueva-Meyer, PG, 2015) |
| " Albendazole (ALB) is being administered with diethyl carbamazine (DEC) in filariasis endemic areas to eliminate lymphatic filariasis (LF) and helminth infections." | 1.42 | Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole. ( Kalimuthu, M; Kumar, VA; Munirathinam, A; Nagaraj, J; Rajendran, R; Sunish, IP; Tyagi, BK, 2015) |
| "In endemic area, intestinal capillariasis should be considered if patients develop chronic watery diarrhea accompanied by significant weight loss and severe hypoalbuminemia." | 1.40 | Intestinal capillariasis in the 21st century: clinical presentations and role of endoscopy and imaging. ( Apisarnthanarak, P; Limsrivilai, J; Manatsathit, S; Pongprasobchai, S, 2014) |
| "We encountered an indigenous case of intestinal capillariasis with protein-losing enteropathy in the Republic of Korea." | 1.38 | An indigenous case of intestinal capillariasis with protein-losing enteropathy in Korea. ( Ha, CY; Jung, WT; Kim, HJ; Ko, GH; Min, HJ; Na, BK; Sohn, WM, 2012) |
| "The combined effect of the Lymphatic Filariasis Elimination Programme (LFEP) and the National Schistosomiasis and Soil-transmitted Helminthiasis Control Programme (NSSCP) on soil-transmitted helminthiasis (STH) was evaluated." | 1.35 | The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania. ( Magnussen, P; Massa, K; Ndawi, B; Ntakamulenga, R; Olsen, A; Sheshe, A, 2009) |
| "The diagnosis of capillariasis was made by enteroscopy after negative repeated stool tests." | 1.34 | The endoscopic-pathologic findings in intestinal capillariais: a case report. ( Kularbkaew, C; Mairiang, P; Sangchan, A; Sawanyawisuth, K; Sukeepaisarnjaroen, W; Wongsaensook, A, 2007) |
| "Praziquantel was used to treat H." | 1.33 | Intestinal helminth infection in an ethnic minority commune in southern Vietnam. ( Binh, TQ; de Vries, PJ; Giao, PT; Kager, PA; Le Hung, Q; Nam, NV, 2005) |
| "Cysticercosis is an helminthic disease which is usually observed in endemic areas or in immigrants coming from these areas." | 1.32 | [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. ( Bricaire, E; Caumes, E; Chemali, N; Danis, M; Epelboin, L; Klement, E, 2004) |
| " This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days." | 1.32 | Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004) |
| "Human intestinal capillariasis is a rare parasitosis that was first recognized in the Philippines in the 1960 s." | 1.32 | Clinical features of human intestinal capillariasis in Taiwan. ( Bair, MJ; Hwang, KP; Kao, CR; Lin, SC; Liou, TC; Pang, KK; Wang, TE; Wang, TY, 2004) |
| "Treatment with albendazole (200 mg) brought about reductions in the level of Trichuris trichiura (to 41." | 1.31 | Intestinal helminthiases and their control with albendazole among primary schoolchildren in riverine communities of Ondo State, Nigeria. ( Ariyo, F; Faweya, T; Monye, P; Okoro, C; Oyewole, F; Oyibo, WA; Sanyaolu, A; Ukpong, M, 2002) |
| "Albendazole was given (2 x 400 mg daily for 6 days, followed by a maintenance dose of 1 x 400 mg daily)." | 1.30 | [Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma]. ( Diehl, V; Fätkenheuer, G; Franzen, C; Müller, A; Salzberger, B; Schrappe, M, 1998) |
| "Multiorgan microsporidiosis due to Enterocytozoon bieneusi was diagnosed in an HIV-infected patient." | 1.30 | Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. ( Allamagny, E; Amiel, C; Canton, P; Georges, E; Guedenet, JC; Kurès, L; May, T; Rabaud, C, 1998) |
| "Albendazole is a new, broad-spectrum antiparasitic drug, which was approved recently by the Food and Drug Administration." | 1.30 | The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. ( Chan, MS; Muennig, P; Pallin, D; Sell, RL, 1999) |
| "Strongyloidiasis has been recognized as one of the life-threatening parasitic infections in the immunocompromised patients." | 1.30 | A case of Strongyloides stercoralis infection. ( Han, JH; Hong, SJ, 1999) |
| "5%), dosed 5 mg/kg of body weight, proved highly effective in the control of gastrointestinal nematodes and Moniezia spp." | 1.30 | [Control of gastrointestinal helminthiasis in pasture-reared lambs]. ( Chroust, K, 1997) |
| "Albendazole was restarted and, after 2 weeks, the patient had negative stool and urine specimens." | 1.30 | A patient with acquired immunodeficiency syndrome and untreated Encephalitozoon (Septata) intestinalis microsporidiosis leading to small bowel perforation. Response to albendazole. ( Becker, RB; Halverson, AL; Orenstein, JM; Pistole, MC; Soule, JB, 1997) |
| " Plasma concentrations of albendazole-sulphoxide (ABZSO) were measured in age matched non-infected mice by high performance liquid chromatography (HPLC), after administration of ABZ or RBZ dosed at 50 mg ABZ equivalent kg-1." | 1.30 | Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. ( Bolás-Fernández, F; Lopez-Garcia, ML; Martínez-Fernández, AR; Torrado-Duran, J; Torrado-Duran, S, 1997) |
| " There are some dosage limitations, but the manufacturer says these limitations can be easily resolved." | 1.29 | Don't get caught with your pants down. ( Learned, J, 1996) |
| "Disseminated microsporidiosis due to the newly described species Septata intestinalis in nine patients infected with human immunodeficiency virus is described." | 1.29 | Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. ( Dore, GJ; Field, AS; Harkness, JL; Hing, MC; Marriott, DJ, 1995) |
| "Strongyloidiasis is a parasitic disease of tropical regions and to some extent of the South of Europe." | 1.28 | [Strongyloidiasis under immunosuppressive therapy]. ( Hanck, C; Holzer, BR, 1992) |
| " Two groups of 20 sheep, one group untreated, the other dosed with a capsule were grazed together; 5 sheep from each group were slaughtered for total worm counts 30 and 101 d after capsules were administered." | 1.28 | The efficacy of a controlled-release albendazole capsule in suppressing nematode burdens in sheep. ( Barton, NJ; Rodden, B; Steel, JW, 1990) |
| "Malaria was holo- to hyperendemic in the community, P." | 1.27 | Longitudinal study on the health status of children in a rural Tanzanian community: parasitoses and nutrition following control measures against intestinal parasites. ( Aellen, M; Betschart, B; Burnier, E; de Savigny, D; Degrémont, AA; Lüdin, E; Marti, HP; Mayombana, C; Suter, R; Tanner, M, 1987) |
| " This is the same dosage used for mebendazole, which has been the drug of choice in treating the parasitosis." | 1.27 | Albendazole in the treatment of intestinal capillariasis. ( Basaca-Sevilla, V; Cross, JH, 1987) |
| " The premix (11 cattle) and drench suspension (9 cattle) were found to have similar efficacies at a dosage of 7." | 1.27 | Efficacy of an albendazole feed formulation against bovine gastrointestinal nematodes including arrested larvae of Ostertagia ostertagi. ( Courtney, CH; Greiner, EC; Whitten, RD, 1986) |
| "Ascariasis was the most prevalent infection." | 1.27 | Albendazole in the treatment of intestinal helminthiasis in children. ( Jagota, SC; Misra, PK; Pande, NK, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (14.29) | 18.7374 |
| 1990's | 64 (33.86) | 18.2507 |
| 2000's | 44 (23.28) | 29.6817 |
| 2010's | 47 (24.87) | 24.3611 |
| 2020's | 7 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Mavrova, ATs | 1 |
| Denkova, P | 1 |
| Tsenov, YA | 1 |
| Anichina, KK | 1 |
| Vutchev, DI | 1 |
| Veesenmeyer, AF | 1 |
| Curico, G | 1 |
| García-Bardales, P | 1 |
| Pinedo, T | 1 |
| Shapiama, W | 1 |
| Moncada-Yaicate, M | 1 |
| Romaina, L | 1 |
| Yori, PP | 1 |
| Paredes-Olortegui, M | 1 |
| Meza-Sánchez, G | 1 |
| Lescano, AG | 1 |
| Paz-Soldan, VA | 1 |
| Schiaffino, F | 1 |
| Oberhelman, RA | 1 |
| Kosek, MN | 1 |
| Gasparinho, C | 1 |
| Gonçalves, MH | 1 |
| Chissaque, A | 1 |
| Silva, GL | 1 |
| Fortes, F | 1 |
| Gonçalves, L | 1 |
| Abo Maged, AI | 1 |
| Metwally, KM | 1 |
| El-Menyawy, HM | 1 |
| Hegab, F | 1 |
| El-Wakil, ES | 1 |
| Oliveira, YLDC | 1 |
| Oliveira, LM | 1 |
| Oliveira, YLM | 1 |
| Nascimento, AMD | 1 |
| La Corte, R | 1 |
| Geraldi, RM | 1 |
| Barbosa, L | 1 |
| Gazzinelli-Guimarães, PH | 1 |
| Fujiwara, RT | 1 |
| Bueno, LL | 1 |
| Dolabella, SS | 1 |
| Bolaños, F | 1 |
| Jurado-Zambrano, LF | 1 |
| Luna-Tavera, RL | 1 |
| Jiménez, JM | 1 |
| Salam, RA | 1 |
| Das, JK | 1 |
| Bhutta, ZA | 1 |
| Belew, S | 2 |
| Suleman, S | 2 |
| Wynendaele, E | 2 |
| D'Hondt, M | 2 |
| Kosgei, A | 1 |
| Duchateau, L | 2 |
| De Spiegeleer, B | 2 |
| Nissan, B | 1 |
| Lachish, T | 1 |
| Schwartz, E | 1 |
| Pacheco, PA | 1 |
| Rodrigues, LNC | 1 |
| Ferreira, JFS | 1 |
| Gomes, ACP | 1 |
| Veríssimo, CJ | 1 |
| Louvandini, H | 1 |
| Costa, RLD | 1 |
| Katiki, LM | 1 |
| Htun, NSN | 1 |
| Odermatt, P | 1 |
| Müller, I | 1 |
| Yap, P | 2 |
| Steinmann, P | 2 |
| Schindler, C | 1 |
| Gerber, M | 1 |
| Du Randt, R | 1 |
| Walter, C | 1 |
| Pühse, U | 1 |
| Utzinger, J | 3 |
| Probst-Hensch, N | 1 |
| Bizimana, P | 1 |
| Polman, K | 1 |
| Van Geertruyden, JP | 1 |
| Nsabiyumva, F | 1 |
| Ngenzebuhoro, C | 1 |
| Muhimpundu, E | 1 |
| Ortu, G | 1 |
| Kugo, M | 1 |
| Keter, L | 1 |
| Maiyo, A | 1 |
| Kinyua, J | 1 |
| Ndemwa, P | 1 |
| Maina, G | 1 |
| Otieno, P | 1 |
| Songok, EM | 1 |
| Mohammedsalih, KM | 1 |
| Khalafalla, A | 1 |
| Bashar, A | 1 |
| Abakar, A | 1 |
| Hessain, A | 1 |
| Juma, FR | 1 |
| Coles, G | 1 |
| Krücken, J | 1 |
| von Samson-Himmelstjerna, G | 1 |
| Finsnes, KD | 1 |
| Bailey, C | 1 |
| Lopez, S | 1 |
| Camero, A | 1 |
| Taiquiri, C | 1 |
| Arhuay, Y | 1 |
| Moore, DA | 1 |
| Tun, A | 1 |
| Myat, SM | 1 |
| Gabrielli, AF | 1 |
| Montresor, A | 1 |
| Albonico, M | 2 |
| Rinaldi, L | 1 |
| Sciascia, S | 1 |
| Morgoglione, ME | 1 |
| Piemonte, M | 1 |
| Maurelli, MP | 1 |
| Musella, V | 1 |
| Ali, SM | 2 |
| Ame, SM | 2 |
| Cringoli, G | 1 |
| Supali, T | 3 |
| Djuardi, Y | 3 |
| Bradley, M | 1 |
| Noordin, R | 1 |
| Rückert, P | 1 |
| Fischer, PU | 1 |
| Giuseppe, S | 1 |
| Francesco, C | 1 |
| Socrate, P | 1 |
| Doriana, V | 1 |
| Carlo, S | 1 |
| Pierluigi, C | 1 |
| Limsrivilai, J | 1 |
| Pongprasobchai, S | 1 |
| Apisarnthanarak, P | 1 |
| Manatsathit, S | 1 |
| Lahariya, C | 1 |
| Menabde, N | 1 |
| Speich, B | 1 |
| Bogoch, II | 1 |
| Alles, R | 1 |
| Huwyler, J | 1 |
| Hattendorf, J | 1 |
| Keiser, J | 1 |
| Cabada, MM | 1 |
| Goodrich, MR | 1 |
| Graham, B | 1 |
| Villanueva-Meyer, PG | 1 |
| Deichsel, EL | 1 |
| Lopez, M | 1 |
| Arque, E | 1 |
| Clinton White, A | 1 |
| Sunish, IP | 1 |
| Rajendran, R | 1 |
| Munirathinam, A | 1 |
| Kalimuthu, M | 1 |
| Kumar, VA | 1 |
| Nagaraj, J | 1 |
| Tyagi, BK | 1 |
| Brückner, S | 1 |
| Agnandji, ST | 1 |
| Berberich, S | 1 |
| Bache, E | 1 |
| Fernandes, JF | 1 |
| Schweiger, B | 1 |
| Massinga Loembe, M | 1 |
| Engleitner, T | 1 |
| Lell, B | 3 |
| Mordmüller, B | 1 |
| Adegnika, AA | 1 |
| Yazdanbakhsh, M | 3 |
| Kremsner, PG | 1 |
| Esen, M | 1 |
| Ramli, I | 1 |
| Amarouch, H | 1 |
| Mael-Ainin, M | 1 |
| Aitourhroui, M | 1 |
| Senouci, K | 1 |
| Hassam, B | 1 |
| Getachew, M | 1 |
| Mohammed, T | 1 |
| Deti, H | 1 |
| Mekonnen, Z | 1 |
| Vercruysse, J | 2 |
| Levecke, B | 1 |
| Siza, JE | 2 |
| Kaatano, GM | 2 |
| Chai, JY | 2 |
| Eom, KS | 2 |
| Rim, HJ | 2 |
| Yong, TS | 2 |
| Min, DY | 2 |
| Chang, SY | 2 |
| Ko, Y | 2 |
| Changalucha, JM | 2 |
| Ghoshal, UC | 1 |
| Venkitaramanan, A | 1 |
| Verma, A | 1 |
| Misra, A | 1 |
| Saraswat, VA | 1 |
| Shiferaw, MB | 1 |
| Mengistu, AD | 1 |
| Easton, AV | 1 |
| Oliveira, RG | 1 |
| O'Connell, EM | 1 |
| Kepha, S | 1 |
| Mwandawiro, CS | 1 |
| Njenga, SM | 1 |
| Kihara, JH | 1 |
| Mwatele, C | 1 |
| Odiere, MR | 1 |
| Brooker, SJ | 1 |
| Webster, JP | 1 |
| Anderson, RM | 1 |
| Nutman, TB | 1 |
| Ramos, F | 1 |
| Portella, LP | 1 |
| Rodrigues, FS | 1 |
| Reginato, CZ | 1 |
| Pötter, L | 1 |
| Cezar, AS | 1 |
| Sangioni, LA | 1 |
| Vogel, FSF | 1 |
| Kumar, A | 2 |
| Nautsch, D | 1 |
| Tamer, GS | 1 |
| Dündar, D | 1 |
| Massa, K | 1 |
| Magnussen, P | 2 |
| Sheshe, A | 1 |
| Ntakamulenga, R | 1 |
| Ndawi, B | 1 |
| Olsen, A | 1 |
| Capece, BP | 1 |
| Virkel, GL | 1 |
| Lanusse, CE | 1 |
| Awasthi, S | 2 |
| Verma, T | 1 |
| Kotecha, PV | 1 |
| Venkatesh, V | 1 |
| Joshi, V | 1 |
| Roy, S | 1 |
| Nga, TT | 2 |
| Winichagoon, P | 2 |
| Dijkhuizen, MA | 2 |
| Khan, NC | 2 |
| Wasantwisut, E | 2 |
| Furr, H | 1 |
| Wieringa, FT | 2 |
| Ramos, A | 1 |
| Giménez, L | 1 |
| Pueyo, A | 1 |
| Cortés, C | 1 |
| Uscátegui, RM | 1 |
| Correa, AM | 1 |
| Carmona-Fonseca, J | 1 |
| Wiria, AE | 2 |
| Prasetyani, MA | 1 |
| Hamid, F | 2 |
| Wammes, LJ | 2 |
| Ariawan, I | 2 |
| Uh, HW | 2 |
| Wibowo, H | 2 |
| Wahyuni, S | 2 |
| Sutanto, I | 1 |
| May, L | 2 |
| Luty, AJ | 1 |
| Verweij, JJ | 2 |
| Sartono, E | 2 |
| Zevallos, K | 1 |
| Vergara, KC | 1 |
| Vergara, A | 1 |
| Vidal, C | 1 |
| Garcia, HH | 2 |
| Evans, CA | 1 |
| Karabiber, H | 1 |
| Oguzkurt, DG | 1 |
| Dogan, DG | 1 |
| Aktas, M | 1 |
| Selimoglu, MA | 1 |
| Altintop, L | 1 |
| Cakar, B | 1 |
| Hokelek, M | 1 |
| Bektas, A | 1 |
| Yildiz, L | 1 |
| Karaoglanoglu, M | 1 |
| Alvarez, L | 1 |
| Entrocasso, C | 1 |
| Lifschitz, A | 1 |
| Manazza, J | 1 |
| Ceballos, L | 1 |
| Borda, B | 1 |
| Lanusse, C | 1 |
| Peterson, LS | 1 |
| Ondiek, M | 1 |
| Oludhe, DO | 1 |
| Naul, BA | 1 |
| Vermund, SH | 1 |
| Kaisar, MM | 1 |
| Schot, R | 1 |
| van Ree, R | 1 |
| Tanveer, MK | 1 |
| Kamran, A | 1 |
| Abbas, M | 1 |
| Umer, NC | 1 |
| Azhar, MA | 1 |
| Munir, M | 1 |
| Bhutia, KL | 1 |
| Dey, S | 1 |
| Singh, V | 1 |
| Gupta, A | 1 |
| Cabrera, F | 1 |
| Attia, RA | 1 |
| Tolba, ME | 1 |
| Yones, DA | 1 |
| Bakir, HY | 1 |
| Eldeek, HE | 1 |
| Kamel, S | 1 |
| Chen, JM | 1 |
| Zhang, XM | 1 |
| Wang, LJ | 1 |
| Chen, Y | 2 |
| Du, Q | 1 |
| Cai, JT | 1 |
| Swanson, SJ | 1 |
| Phares, CR | 1 |
| Mamo, B | 1 |
| Smith, KE | 1 |
| Cetron, MS | 1 |
| Stauffer, WM | 1 |
| Bhoite, RM | 1 |
| Iyer, UM | 1 |
| Jung, WT | 1 |
| Kim, HJ | 2 |
| Min, HJ | 1 |
| Ha, CY | 1 |
| Ko, GH | 1 |
| Na, BK | 1 |
| Sohn, WM | 1 |
| Mohammed, KA | 1 |
| Deb, RM | 1 |
| Stanton, MC | 1 |
| Molyneux, DH | 1 |
| Sherkhonov, T | 1 |
| Mammadov, S | 1 |
| Sayfuddin, K | 1 |
| Martinez, P | 1 |
| Amoss, WP | 1 |
| Wientzen, RL | 1 |
| Oyewole, F | 1 |
| Ariyo, F | 1 |
| Sanyaolu, A | 1 |
| Oyibo, WA | 1 |
| Faweya, T | 1 |
| Monye, P | 1 |
| Ukpong, M | 1 |
| Okoro, C | 1 |
| Atanásio, A | 1 |
| Boomker, J | 1 |
| Sitoe, C | 1 |
| Maingi, N | 2 |
| Otieno, RO | 1 |
| Gichohi, VM | 2 |
| Weda, EH | 1 |
| Penalva, JC | 1 |
| Sáez, J | 1 |
| Carnicer, F | 1 |
| Griño, P | 1 |
| Company, L | 1 |
| Laveda, R | 1 |
| Wen, LY | 3 |
| Xia, ZH | 1 |
| Yao, SY | 1 |
| Yang, JS | 2 |
| Cheng, GQ | 1 |
| Su, YL | 1 |
| Song, CC | 1 |
| Zhang, T | 1 |
| Shen, YP | 2 |
| Liu, Y | 1 |
| Yang, WP | 2 |
| Shao, JO | 2 |
| Ju, SY | 1 |
| Dong, K | 2 |
| Xu, JL | 1 |
| Jiang, JM | 1 |
| Hoque, MN | 1 |
| Begum, N | 1 |
| Nooruddin, M | 1 |
| Li, SW | 1 |
| Wu, LJ | 1 |
| Yan, XL | 2 |
| Yang, MJ | 2 |
| Lou, LJ | 2 |
| Zhan, FC | 1 |
| Wang, XY | 1 |
| Li, TR | 1 |
| Shao, JQ | 1 |
| Zheng, JC | 1 |
| Fu, MH | 1 |
| Mortensen, LL | 1 |
| Williamson, LH | 1 |
| Terrill, TH | 1 |
| Kircher, RA | 1 |
| Larsen, M | 1 |
| Kaplan, RM | 1 |
| Geltman, PL | 1 |
| Cochran, J | 1 |
| Hedgecock, C | 1 |
| Tanumihardjo, SA | 1 |
| Permaesih, D | 1 |
| Bair, MJ | 1 |
| Hwang, KP | 1 |
| Wang, TE | 1 |
| Liou, TC | 1 |
| Lin, SC | 1 |
| Kao, CR | 1 |
| Wang, TY | 1 |
| Pang, KK | 1 |
| De Rochars, MB | 1 |
| Direny, AN | 1 |
| Roberts, JM | 2 |
| Addiss, DG | 2 |
| Radday, J | 1 |
| Beach, MJ | 2 |
| Streit, TG | 2 |
| Dardith, D | 1 |
| Lafontant, JG | 1 |
| Lammie, PJ | 2 |
| Narain, K | 1 |
| Medhi, GK | 1 |
| Rajguru, SK | 1 |
| Mahanta, J | 1 |
| Pornsuriyasak, P | 1 |
| Niticharoenpong, K | 1 |
| Sakapibunnan, A | 1 |
| Scheid, PL | 1 |
| Traue, CM | 1 |
| Sur, D | 1 |
| Saha, DR | 1 |
| Manna, B | 1 |
| Rajendran, K | 1 |
| Bhattacharya, SK | 1 |
| Waikagul, J | 1 |
| Watthanakulpanich, D | 1 |
| Muennoo, C | 1 |
| Maipanich, W | 1 |
| Sa-nguankiat, S | 1 |
| Phubampen, S | 1 |
| Wichro, E | 1 |
| Hoelzl, D | 1 |
| Krause, R | 1 |
| Bertha, G | 1 |
| Reinthaler, F | 1 |
| Wenisch, C | 1 |
| Le Hung, Q | 1 |
| de Vries, PJ | 1 |
| Giao, PT | 1 |
| Binh, TQ | 1 |
| Nam, NV | 1 |
| Kager, PA | 1 |
| Sahoo, PK | 1 |
| Satapathy, AK | 1 |
| Michael, E | 1 |
| Ravindran, B | 1 |
| Teneza-Mora, NC | 1 |
| Lavery, EA | 1 |
| Chun, HM | 1 |
| Wu, ZX | 1 |
| Fang, YY | 2 |
| Liu, YS | 1 |
| Soroczan, W | 1 |
| Rey, P | 1 |
| Debonne, JM | 1 |
| Epelboin, L | 1 |
| Klement, E | 1 |
| Chemali, N | 1 |
| Danis, M | 1 |
| Bricaire, E | 1 |
| Caumes, E | 1 |
| Hosseinipour, MC | 1 |
| Napravnik, S | 1 |
| Joaki, G | 1 |
| Gama, S | 1 |
| Mbeye, N | 1 |
| Banda, B | 1 |
| Martinson, F | 1 |
| Hoffman, I | 1 |
| Cohen, MS | 1 |
| Sangchan, A | 1 |
| Wongsaensook, A | 1 |
| Kularbkaew, C | 1 |
| Sawanyawisuth, K | 1 |
| Sukeepaisarnjaroen, W | 1 |
| Mairiang, P | 1 |
| Flisser, A | 1 |
| Valdespino, JL | 1 |
| García-García, L | 1 |
| Guzman, C | 1 |
| Aguirre, MT | 1 |
| Manon, ML | 1 |
| González-González, G | 1 |
| Gyorkos, TW | 1 |
| Peto, R | 1 |
| Pande, VK | 1 |
| Fletcher, RH | 1 |
| Read, S | 1 |
| Bundy, DA | 2 |
| Sun, FH | 1 |
| Coulaud, JP | 1 |
| Rossignol, JF | 3 |
| Maisonneuve, H | 2 |
| Pungpark, S | 1 |
| Bunnag, D | 1 |
| Harinasuta, T | 1 |
| Lara-Aguilera, R | 1 |
| Vallejo-Aguilar, O | 1 |
| Gómez-Rojo, E | 1 |
| Guzmán-Bracho, C | 1 |
| Chen, ZJ | 1 |
| Chen, ER | 1 |
| Yen, CM | 1 |
| Shih, CC | 1 |
| Hsieh, HC | 1 |
| Chandiwana, SK | 1 |
| Makaza, D | 1 |
| Makura, O | 1 |
| Chaudhry, RA | 1 |
| Gunnarsson, G | 1 |
| Hurlbut, D | 1 |
| DeGirolami, PC | 2 |
| Federman, M | 2 |
| Wanke, C | 1 |
| Dore, GJ | 1 |
| Marriott, DJ | 1 |
| Hing, MC | 1 |
| Harkness, JL | 1 |
| Field, AS | 1 |
| Wilairatana, P | 1 |
| Molina, JM | 1 |
| Oksenhendler, E | 1 |
| Beauvais, B | 1 |
| Sarfati, C | 1 |
| Jaccard, A | 1 |
| Derouin, F | 1 |
| Modaï, J | 1 |
| Oldfield, EC | 1 |
| Phuvanandh, D | 1 |
| Dulyapiree, Y | 1 |
| Chatisiri, J | 1 |
| Panrong, A | 1 |
| Tanskul, P | 1 |
| Phuvanandh, M | 1 |
| Asmuth, DM | 1 |
| Ezratty, CR | 1 |
| Pleskow, DK | 1 |
| Desai, G | 1 |
| Wanke, CA | 1 |
| Gan, Y | 1 |
| Wu, Q | 1 |
| Ou, F | 1 |
| Li, G | 1 |
| Huang, J | 1 |
| Wei, Q | 1 |
| Nong, C | 1 |
| Nong, L | 1 |
| Zhong, T | 1 |
| Hu, YL | 1 |
| Xu, ZL | 1 |
| Corba, J | 2 |
| Krupicer, I | 1 |
| Várady, M | 2 |
| Pet'ko, B | 1 |
| Praslicka, J | 1 |
| Vesely, L | 1 |
| Anderson, N | 2 |
| Petch, DA | 1 |
| Tan, LX | 1 |
| Gong, XH | 1 |
| Su, C | 1 |
| Guo, ZM | 1 |
| Blanshard, C | 1 |
| Ellis, DS | 1 |
| Dowell, SP | 1 |
| Tovey, G | 1 |
| Gazzard, BG | 1 |
| Liu, LX | 1 |
| Weller, PF | 1 |
| Dieterich, DT | 1 |
| Lew, EA | 1 |
| Kotler, DP | 1 |
| Poles, MA | 1 |
| Orenstein, JM | 2 |
| Curry, A | 1 |
| Canning, EU | 1 |
| Svenson, J | 1 |
| MacLean, JD | 1 |
| Kokoskin-Nelson, E | 1 |
| Szabo, J | 1 |
| Lough, J | 1 |
| Gill, MJ | 1 |
| Echevarria, FA | 1 |
| Armour, J | 1 |
| Bairden, K | 1 |
| Duncan, JL | 1 |
| Shah, V | 1 |
| Marino, C | 1 |
| Altice, FL | 1 |
| Gopaldas, T | 1 |
| Bassetti, S | 1 |
| Chroust, K | 1 |
| Mukhwana, EJ | 1 |
| Mitema, ES | 2 |
| Sreenivas, DV | 1 |
| Kumar, YR | 1 |
| Bharavi, C | 1 |
| Sundaram, C | 1 |
| Gayathri, K | 1 |
| Soule, JB | 1 |
| Halverson, AL | 1 |
| Becker, RB | 1 |
| Pistole, MC | 1 |
| Lopez-Garcia, ML | 1 |
| Torrado-Duran, S | 1 |
| Torrado-Duran, J | 1 |
| Martínez-Fernández, AR | 1 |
| Bolás-Fernández, F | 1 |
| Furnée, CA | 1 |
| West, CE | 1 |
| van der Haar, F | 1 |
| Hautvast, JG | 1 |
| Thamsborg, SM | 1 |
| Munyua, WK | 1 |
| Gathuma, JM | 1 |
| Müller, A | 1 |
| Fätkenheuer, G | 1 |
| Salzberger, B | 1 |
| Schrappe, M | 1 |
| Diehl, V | 1 |
| Franzen, C | 1 |
| Georges, E | 1 |
| Rabaud, C | 1 |
| Amiel, C | 1 |
| Kurès, L | 1 |
| Guedenet, JC | 1 |
| Allamagny, E | 1 |
| May, T | 1 |
| Canton, P | 1 |
| Mbaria, JM | 1 |
| Maitho, TE | 1 |
| Muchiri, DJ | 1 |
| Dionisio, D | 1 |
| Manneschi, LI | 1 |
| Di Lollo, S | 1 |
| Orsi, A | 1 |
| Sterrantino, G | 1 |
| Leoncini, F | 1 |
| Pozzi, M | 1 |
| Vinattieri, MA | 1 |
| Tani, A | 1 |
| Papucci, A | 1 |
| Muennig, P | 1 |
| Pallin, D | 1 |
| Sell, RL | 1 |
| Chan, MS | 1 |
| Kucerová-Pospísilová, Z | 1 |
| Stanková, M | 1 |
| Ditrich, O | 1 |
| Takeuchi, T | 1 |
| Mascie-Taylor, CG | 1 |
| Alam, M | 1 |
| Montanari, RM | 1 |
| Karim, R | 1 |
| Ahmed, T | 1 |
| Karim, E | 1 |
| Akhtar, S | 1 |
| Al-Qudah, KM | 1 |
| Sharif, LA | 1 |
| Al-Rawashdeh, OF | 1 |
| Al-Ani, FK | 1 |
| Hong, SJ | 1 |
| Han, JH | 1 |
| Prospere, R | 1 |
| Satoh, M | 2 |
| Toma, H | 2 |
| Sato, Y | 2 |
| Kikuchi, M | 1 |
| Takara, M | 2 |
| Shiroma, Y | 2 |
| Kiyuna, S | 2 |
| Hirayama, K | 2 |
| Sangmaneedet, S | 1 |
| Smith, SA | 1 |
| Lee, KJ | 2 |
| Lee, IY | 1 |
| Im, K | 1 |
| Torlesse, H | 1 |
| Hodges, M | 1 |
| Muchiri, EM | 1 |
| Thiong'o, FW | 1 |
| Ouma, JH | 1 |
| Learned, J | 1 |
| Ahn, YK | 1 |
| Ryang, YS | 1 |
| Chokephaibulkit, K | 1 |
| Wanachiwanawin, D | 1 |
| Tosasuk, K | 1 |
| Pavitpok, J | 1 |
| Vanprapar, N | 1 |
| Chearskul, S | 1 |
| Zhang, D | 1 |
| Zhang, X | 1 |
| Tang, Z | 1 |
| Chen, C | 1 |
| Yang, W | 1 |
| Jin, M | 1 |
| Huang, C | 1 |
| Yang, G | 1 |
| Long, Y | 1 |
| Bany, J | 1 |
| Lach, J | 1 |
| Golińska, Z | 1 |
| Chan, L | 1 |
| Kan, SP | 1 |
| Louw, JP | 2 |
| Reinecke, RK | 2 |
| Bell, SL | 1 |
| Thomas, RJ | 1 |
| McDougall, S | 1 |
| Sangster, NC | 1 |
| Rickard, JM | 1 |
| Collins, GH | 1 |
| Hennessy, DR | 1 |
| Steel, JW | 2 |
| Hanck, C | 1 |
| Holzer, BR | 1 |
| Chichino, G | 1 |
| Bernuzzi, AM | 1 |
| Bruno, A | 1 |
| Cevini, C | 1 |
| Atzori, C | 1 |
| Malfitano, A | 1 |
| Scaglia, M | 1 |
| Hanjeet, K | 1 |
| Mathias, RG | 1 |
| Williams, JC | 1 |
| Chacín-Bonilla, L | 1 |
| Mylrea, GE | 1 |
| Mulley, RC | 1 |
| English, AW | 1 |
| Schnieder, T | 1 |
| Lotze, R | 1 |
| Stoye, M | 1 |
| Ward, JK | 1 |
| Ferguson, DL | 1 |
| Parkhurst, AM | 1 |
| Berthelsen, J | 1 |
| Nelson, MJ | 1 |
| Barton, NJ | 1 |
| Rodden, B | 1 |
| Raccurt, CP | 1 |
| Lambert, MT | 1 |
| Bouloumie, J | 1 |
| Ripert, C | 1 |
| Biddulph, J | 1 |
| Ploeger, HW | 1 |
| van Straalen, W | 1 |
| Borgsteede, FH | 1 |
| Eysker, M | 2 |
| Kloosterman, A | 2 |
| Charles, TP | 1 |
| Pompeu, J | 1 |
| Miranda, DB | 1 |
| Martin, PJ | 1 |
| Jarrett, RG | 1 |
| Tanner, M | 1 |
| Burnier, E | 1 |
| Mayombana, C | 1 |
| Betschart, B | 1 |
| de Savigny, D | 1 |
| Marti, HP | 1 |
| Suter, R | 1 |
| Aellen, M | 1 |
| Lüdin, E | 1 |
| Degrémont, AA | 1 |
| Kuźmicki, R | 1 |
| Lasociński, M | 1 |
| Ahmad, A | 1 |
| Zohra, A | 1 |
| Yasmin, N | 1 |
| Dorny, P | 1 |
| Hilderson, H | 1 |
| Berghen, P | 1 |
| Van Ommeslaeghe, K | 1 |
| Cross, JH | 1 |
| Basaca-Sevilla, V | 1 |
| Jagota, SC | 3 |
| Zawde, D | 1 |
| Boulos, LM | 1 |
| Abu Samra, LM | 1 |
| Amin, SM | 1 |
| el Nasery, SF | 1 |
| Youssef, MM | 1 |
| Pamba, HO | 1 |
| Bwibo, NO | 1 |
| Chunge, CN | 1 |
| Estambale, BB | 1 |
| Qian, MX | 1 |
| Liu, YH | 1 |
| Wang, XG | 1 |
| Broor, SL | 1 |
| Bassi, SS | 1 |
| Broor, S | 1 |
| Jansen, J | 1 |
| Kooyman, FN | 1 |
| Mirck, MH | 1 |
| Wensing, T | 1 |
| Courtney, CH | 1 |
| Greiner, EC | 1 |
| Whitten, RD | 1 |
| Prasad, R | 1 |
| Mathur, PP | 1 |
| Taneja, VK | 1 |
| Mbendi, N | 1 |
| Mashako, MM | 1 |
| Herabo, M | 1 |
| Bahavu, WM | 1 |
| Misra, PK | 1 |
| Pande, NK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| S. Japonicum and Pregnancy Outcomes: A Randomized, Double Blind, Placebo Controlled Trial (RCT)[NCT00486863] | Phase 2 | 370 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| Activity of Mefloquine Against Urinary Schistosomiasis[NCT01132248] | Phase 2 | 65 participants (Actual) | Interventional | 2010-05-31 | Completed | ||
| Clinical Evaluation of Ujiplus®, a Porridge Snack With Deworming Properties for Activity Against Schistosoma Mansoni[NCT04679831] | Phase 2/Phase 3 | 400 participants (Actual) | Interventional | 2021-05-06 | Completed | ||
| Design and Clinical Evaluation of a School Meal With Deworming Properties[NCT02725255] | Phase 2/Phase 3 | 326 participants (Actual) | Interventional | 2015-05-31 | Completed | ||
| Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections, Growth, Iron Status and Educational Achievement Among Orang Asli Schoolchildren in Pos Betau, Pahang, Malaysia[NCT00936091] | 250 participants (Actual) | Interventional | 2007-05-31 | Completed | |||
| To Assess the Effectiveness of Six-Monthly Deworming With Vitamin A Administration on Growth in 1-5 Year Old Children in the Urban Slums of Lucknow[NCT00396500] | Phase 3 | 4,000 participants | Interventional | 1994-04-30 | Completed | ||
| Effect of Albendazole and Ivermectin Dose on Wuchereria Bancrofti Microfilarial Clearance in Mali: A Randomized, Open Label Study[NCT00339417] | Phase 2 | 1,000 participants (Anticipated) | Interventional | 2006-02-22 | Completed | ||
| Treatment of Mansonella Perstans Infection in an Area Coendemic for Lymphatic Filariasis: A Pilot Study of the Effects of Doxycycline[NCT00340691] | Phase 2 | 1,500 participants | Interventional | 2004-12-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Hemoglobin concentration in a venous blood sample collected at 14 and 32 weeks gestation was measured using a multi-analyte analyzer. Each participant's change in hemoglobin concentration between the two timepoints was determined, and the mean and standard deviation for each group calculated. (NCT00486863)
Timeframe: 14 weeks and 32 weeks gestation
| Intervention | grams/deciliter (Mean) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | -0.42 |
| Praziquantel at 12-16 Weeks Gestation | -0.44 |
Maternal fat stores were measured by thigh skinfold thickness obtained using a Holtain skinfold caliper. The thickness increase from 14 to 32 weeks was determined for each participant, and the mean and standard deviation calculated. (NCT00486863)
Timeframe: 14 and 32 weeks gestation
| Intervention | millimeters (Mean) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0.08 |
| Praziquantel at 12-16 Weeks Gestation | 0.08 |
Maternal weight gain was assessed by measuring participants' weight in kilograms. The weight increase from 14 to 32 weeks was determined for each participant, and the mean and standard deviation calculated. (NCT00486863)
Timeframe: 14 and 32 weeks gestation
| Intervention | kilograms (Mean) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0.33 |
| Praziquantel at 12-16 Weeks Gestation | 0.32 |
Birth weight was collected for live infants at the time of delivery by a trained midwife, or within 24 hours of delivery for participants who chose to deliver at home with a helot, a birth attendant without formal training. (NCT00486863)
Timeframe: Within 24 hours of delivery.
| Intervention | kilograms (Mean) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 2.85 |
| Praziquantel at 12-16 Weeks Gestation | 2.85 |
To assess total body iron, one needs to assess the storage compartment, which will contain sequestered iron, and the functional compartment, which represents bioavailable iron. Body iron status is defined by the two laboratory measurements that reflect these compartments, ferritin and serum transferrin receptor. The serum transferrin receptor:ferritin ratio has been shown in quantitative phlebotomy studies to provide an accurate assessment of total body iron over the entire range of status. At 14 and 32 weeks gestation, a blood sample was collected for assessment of total body iron by determination of the transferrin receptor:ferritin ratio. Each participant's change in ratio was calculated, and the median and interquartile range were determined for each group. (NCT00486863)
Timeframe: 14 weeks and 32 weeks gestation
| Intervention | ratio (Median) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0.0 |
| Praziquantel at 12-16 Weeks Gestation | 0.0 |
Anemia of inflammation was assessed via maternal urine hepcidin levels. In response to inflammation, elevated serum levels of hepcidin is synthesized. Hepcidin causes sequestration of iron from bio-available forms to storage forms such as ferritin and decreases intestinal absorption of iron. Hepcidin was measured in participants' urine at 32 weeks gestation. (NCT00486863)
Timeframe: 32 weeks gestation
| Intervention | nanograms/milliliter (Median) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 2.58 |
| Praziquantel at 12-16 Weeks Gestation | 3.38 |
Abortion was defined by the protocol as bleeding followed by fetal loss as supported by ultrasound before 20 weeks gestation. Abortion was an important safety outcome measure due to the fact that abortion would occur closer to the time of dosing than miscarriage or stillbirth. Participants were observed in hospital for 24 hours after dosing and asked to return for any bleeding at any time. (NCT00486863)
Timeframe: After dosing and before 20 weeks gestation
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0 |
| Praziquantel at 12-16 Weeks Gestation | 0 |
Participants were observed in hospital for 24 hours after dosing for serious adverse events. Serious adverse events included any untoward medical occurrence that resulted in death; was life threatening; was a persistent/significant disability/incapacity; required in-patient hospitalization or prolongation thereof (for reasons other than the 24-hour observation period); resulted in a congenital anomaly/birth defect; or may have jeopardized the participant, or required intervention to prevent one of these outcomes. (NCT00486863)
Timeframe: Within 24 hours of dosing
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0 |
| Praziquantel at 12-16 Weeks Gestation | 0 |
The newborn was examined by the midwife at delivery and within 2-6 days of delivery to assess the presence of congenital anomalies and well-being. The newborn was also examined by study pediatrician at 28 days of life. (NCT00486863)
Timeframe: At delivery, within 2-6 days of delivery, and at 28 days
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 1 |
| Praziquantel at 12-16 Weeks Gestation | 1 |
Each participant was followed until delivery to record if the outcome of the pregnancy was a live birth. Live births were defined as the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of the pregnancy, which, after such separation, breathes or shows any other evidence of life such as heartbeat, umbilical cord pulsation, or definite movement of voluntary muscles, whether the umbilical cord had been cut or the placenta was attached. (NCT00486863)
Timeframe: At delivery
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 181 |
| Praziquantel at 12-16 Weeks Gestation | 181 |
Participants were assessed for the presence of pre-eclampsia at both the 22 and 32 week visits. Pre-eclampsia was defined by the presence of proteinurea (2+ protein on urine dipstick) and a single diastolic blood pressure reading of 100 millimiters of mercury (mm Hg) or above OR more than one reading, four hours apart, of 90 mm Hg or above. (NCT00486863)
Timeframe: 22 weeks and 32 weeks
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 0 |
| Praziquantel at 12-16 Weeks Gestation | 0 |
Parasitologic response to treatment was evaluated by counting S. japonicum eggs per gram of stool at screening and again at 22 weeks gestation. Success of treatment was pre-specified as greater than 90 percent reduction in egg count from screening to 22 weeks gestation. (NCT00486863)
Timeframe: Screening and 22 weeks gestation
| Intervention | participants (Number) |
|---|---|
| Placebo Control at 12-16 Weeks Gestation | 92 |
| Praziquantel at 12-16 Weeks Gestation | 157 |
Since pregnancy is associated with increased cytochrome P450 activity and physiologic changes in the gastrointestinal tract that tend to reduce drug absorption, praziquantel pharmacokinetics may be affected by pregnancy. Thus, the metabolite-to-parent drug ratio may serve as a differential marker to help determine if variability in drug exposure following oral administration during pregnancy is due to altered metabolism or drug absorption. Samples that were collected from subjects who were randomized to receive praziquantel were analyzed for praziquantel and 4-hydroxy praziquantel concentrations. Assays were performed using high performance liquid chromatography-electrospray mass spectrometry in the University of California at San Diego Pediatric Clinical Pharmacology Laboratory. Descriptive statistics were obtained for concentrations at each of the four sparse sampling timepoints. (NCT00486863)
Timeframe: 4.5 and 8 hours after the first praziquantel dose (subjects assigned to an even study number) or 6 and 10 hours after the first praziquantel dose (subjects assigned to an odd study number).
| Intervention | ng/ml (Median) | |||
|---|---|---|---|---|
| 4.5 Hours, n=50 | 6 Hours, n=49 | 8 Hours, n=50 | 10 Hours, n=49 | |
| Praziquantel at 12-16 Weeks Gestation | 4020.1 | 4590.8 | 5373.7 | 4304.1 |
To assess total body iron, the serum transferrin receptor:ferritin ratio was assessed in the infant. At delivery, a heel stick blood sample and a cord blood sample were collected for assessment of total body iron by determination of the transferrin receptor:ferritin ratio. (NCT00486863)
Timeframe: 0-6 days after delivery.
| Intervention | ratio (Median) | |
|---|---|---|
| Cord Blood | Heel Stick | |
| Placebo Control at 12-16 Weeks Gestation | 1.76 | 0.00 |
| Praziquantel at 12-16 Weeks Gestation | 1.33 | 0.00 |
Toxicity to maternal kidney and liver was assessed by laboratory parameters collected just before and 24 hours after dosing. Specifically, blood was drawn just before the dose at 12-16 weeks gestation to determine baseline blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin. Blood was then drawn 24 hours after the second part of the split dose and before discharge from the hospital to assess any changes in these parameters. Any values that were 1.1 times the upper limit of normal or greater for the parameter were considered abnormal. (NCT00486863)
Timeframe: Just before and 24 hours after dosing
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| Blood Urea Nitrogen (BUN) Abnormal | Creatinine Abnormal | Aspartate Aminotransferase (AST) Abnormal | Alanine Aminotransferase (ALT) Abnormal | Bilirubin Abnormal | |
| Placebo Control at 12-16 Weeks Gestation | 127 | 23 | 8 | 13 | 127 |
| Praziquantel at 12-16 Weeks Gestation | 137 | 39 | 9 | 10 | 137 |
Toxicity to maternal bone marrow, kidney, and liver was assessed by laboratory parameters collected just before and 24 hours after dosing. Specifically, blood was drawn just before the dose at 12-16 weeks gestation to determine baseline complete blood count, including white blood count (WBC), platelets, and hemoglobin. Blood was then drawn 24 hours after the second part of the split dose and before discharge from the hospital to assess any changes in these parameters. White blood count was abnormal at or above 10,800 or at or below 3500 cells/square millimeter (sq mm), platelets were abnormal at or below 140,000 cells/sq mm, and hemoglobin was abnormal at or below 10.9 grams/deciliter (g/dL). (NCT00486863)
Timeframe: Just before and 24 hours after dosing
| Intervention | participants (Number) | ||
|---|---|---|---|
| White Blood Cell Abnormal | Platelets Abnormal | Hemoglobin Abnormal | |
| Placebo Control at 12-16 Weeks Gestation | 69 | 3 | 54 |
| Praziquantel at 12-16 Weeks Gestation | 60 | 0 | 56 |
Two plasma samples were collected during the overnight hospitalization from approximately 200 subjects that remained at the time of study modification to incorporate PK studies. Subjects had samples collected based on one of two sample collection strategies: 4.5 and 8 hr after the first praziquantel dose or 6 and 10 hr after the first praziquantel dose. Subjects randomized to an even study number were assigned to the 4.5 and 8 hour schedule. Subjects randomized to an odd study number were assigned to the 6 and 10 hour schedule. Samples only from subjects randomized to receive praziquantel were analyzed for praziquantel. Samples drawn from subjects randomized to the control group were not analyzed. Praziquantel concentrations (ng/ml) were assayed using high performance liquid chromatography-electrospray mass spectrometry in the University of California at San Diego Pediatric Clinical Pharmacology Laboratory. (NCT00486863)
Timeframe: 4.5 and 8 hours after the first praziquantel dose (subjects assigned to an even study number) or 6 and 10 hours after the first praziquantel dose (subjects assigned to an odd study number).
| Intervention | ng/mL (Median) | |||
|---|---|---|---|---|
| 4.5 Hours, n=50 | 6 Hours, n=49 | 8 Hours, n=50 | 10 Hours, n=49 | |
| Praziquantel at 12-16 Weeks Gestation | 814.7 | 945.2 | 687.8 | 422.2 |
15 reviews available for albendazole and Intestinal Diseases, Parasitic
| Article | Year |
|---|---|
Important Nematodes in Children.
Topics: Adolescent; Albendazole; Ancylostoma; Anemia; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoid | 2022 |
Abdominal angiostrongyliasis, report of two cases and analysis of published reports from Colombia.
Topics: Albendazole; Angiostrongylus; Animals; Anthelmintics; Appendicitis; Burkitt Lymphoma; Child; Child, | 2020 |
Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.
Topics: Albendazole; Anemia, Iron-Deficiency; Anthelmintics; Bias; Female; Helminthiasis; Humans; Intestinal | 2021 |
Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.
Topics: Albendazole; Anemia, Iron-Deficiency; Anthelmintics; Bias; Female; Helminthiasis; Humans; Intestinal | 2021 |
Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.
Topics: Albendazole; Anemia, Iron-Deficiency; Anthelmintics; Bias; Female; Helminthiasis; Humans; Intestinal | 2021 |
Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.
Topics: Albendazole; Anemia, Iron-Deficiency; Anthelmintics; Bias; Female; Helminthiasis; Humans; Intestinal | 2021 |
Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications.
Topics: Albendazole; Animals; Animals, Domestic; Anthelmintics; Fenbendazole; Intestinal Diseases, Parasitic | 2009 |
[Strongyloidosis. Part IX. Treatment].
Topics: Albendazole; Animals; Anticestodal Agents; Benzimidazoles; Cambendazole; Dose-Response Relationship, | 2002 |
[Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults].
Topics: Albendazole; Ancylostomiasis; Anthelmintics; Artemether; Artemisinins; Benzimidazoles; Drug Resistan | 2006 |
[Present status of the treatment of helminthiasis].
Topics: Albendazole; Anthelmintics; Benzimidazoles; Cestode Infections; Echinococcosis; Helminthiasis; Human | 1984 |
Benzimidazoles in the treatment of trichuriasis: a review.
Topics: Albendazole; Antinematodal Agents; Benzimidazoles; Drug Administration Schedule; Humans; Intestinal | 1984 |
Multiorgan microsporidiosis: report of five cases and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Biliary Tract Dis | 1995 |
Clinical features of microsporidiosis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Boston; CD4-Positive T-Lymphocyt | 1994 |
Strongyloidiasis and other intestinal nematode infections.
Topics: Adult; Albendazole; Animals; Dogs; Female; Humans; Intestinal Diseases, Parasitic; Ivermectin; Male; | 1993 |
Human microsporidiosis.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Eye Infections, Parasitic; Humans; Inte | 1993 |
Albendazole-induced pseudomembranous colitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Anthelmintics; Chronic Disease; Diarrhea; | 1996 |
[Trichuriasis].
Topics: Albendazole; Animals; Antinematodal Agents; Diagnosis, Differential; Humans; Intestinal Diseases, Pa | 1999 |
[Systemic strongyloidiasis. Review].
Topics: Albendazole; Animals; Disease Susceptibility; Humans; Immunocompromised Host; Intestinal Diseases, P | 1991 |
43 trials available for albendazole and Intestinal Diseases, Parasitic
| Article | Year |
|---|---|
Resistance to single dose albendazole and reinfection with intestinal helminths among children ages 2 to 11 years from the Peruvian Amazon region: a study protocol.
Topics: Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Feces; Helminthiasis; Helminths; Human | 2022 |
Wasting, Stunting, and Anemia in Angolan Children after Deworming with Albendazole or a Test-and-Treat Approach for Intestinal Parasites: Binary Longitudinal Models with Temporal Structure in a Four-Arm Randomized Trial.
Topics: Albendazole; Anemia; Animals; Cachexia; Child; Child, Preschool; Diarrhea; Growth Disorders; Humans; | 2022 |
Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; beta-C | 2018 |
Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey.
Topics: Albendazole; Anthelmintics; Carica; Child; Feces; Female; Food, Fortified; Fruit; Helminthiasis; Hum | 2018 |
Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey.
Topics: Albendazole; Anthelmintics; Carica; Child; Feces; Female; Food, Fortified; Fruit; Helminthiasis; Hum | 2018 |
Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey.
Topics: Albendazole; Anthelmintics; Carica; Child; Feces; Female; Food, Fortified; Fruit; Helminthiasis; Hum | 2018 |
Fortification of Carica papaya fruit seeds to school meal snacks may aid Africa mass deworming programs: a preliminary survey.
Topics: Albendazole; Anthelmintics; Carica; Child; Feces; Female; Food, Fortified; Fruit; Helminthiasis; Hum | 2018 |
Epidemiology of strongyle nematode infections and first report of benzimidazole resistance in Haemonchus contortus in goats in South Darfur State, Sudan.
Topics: Albendazole; Animals; Antinematodal Agents; Drug Resistance; Female; Goat Diseases; Goats; Haemonchi | 2019 |
Comparison of three copromicroscopic methods to assess albendazole efficacy against soil-transmitted helminth infections in school-aged children on Pemba Island.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Feces; Female; Helminthiasis; Humans; Indian Ocean Is | 2013 |
Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled t
Topics: Administration, Oral; Adolescent; Albendazole; Animals; Anthelmintics; Child; Drug Therapy, Combinat | 2015 |
Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial.
Topics: Albendazole; Anthelmintics; Antibodies, Viral; B-Lymphocytes; Child; Double-Blind Method; Female; Ga | 2015 |
Assessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, Ethiopia.
Topics: Administration, Oral; Adolescent; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascariasis | 2015 |
Multi-micronutrient-fortified biscuits decreased prevalence of anemia and improved micronutrient status and effectiveness of deworming in rural Vietnamese school children.
Topics: Albendazole; Anemia; Child; Double-Blind Method; Ferritins; Food, Fortified; Hemoglobins; Humans; In | 2009 |
[Changes in retinol, hemoglobin and ferritin concentrations in Colombian children with malaria].
Topics: Albendazole; Anemia; Antimalarials; C-Reactive Protein; Child; Child, Preschool; Colombia; Comorbidi | 2009 |
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study).
Topics: Albendazole; Animals; Anthelmintics; Cytokines; Double-Blind Method; Helminthiasis; Incidence; Indon | 2010 |
Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections.
Topics: Adult; Albendazole; Anthelmintics; Double-Blind Method; Endemic Diseases; Feces; Female; Helminthias | 2010 |
A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study).
Topics: Albendazole; Allergens; Animals; Anthelmintics; Asthma; Child; Child, Preschool; Dermatitis, Atopic; | 2011 |
Decreased parasite load and improved cognitive outcomes caused by deworming and consumption of multi-micronutrient fortified biscuits in rural Vietnamese schoolchildren.
Topics: Albendazole; Anthelmintics; Child; Double-Blind Method; Drug Therapy, Combination; Female; Food; Hum | 2011 |
Effect of deworming vs Iron-Folic acid supplementation plus deworming on growth, hemoglobin level, and physical work capacity of schoolchildren.
Topics: Albendazole; Anemia, Iron-Deficiency; Anthelmintics; Antibiotic Prophylaxis; Body Size; Case-Control | 2012 |
[Clinical observation on the efficacy of ivermectin in the treatment of intestinal nematode infections].
Topics: Adolescent; Adult; Aged; Albendazole; Antinematodal Agents; Child; Humans; Intestinal Diseases, Para | 2003 |
Vitamin A status and hemoglobin concentrations are improved in Indonesian children with vitamin A and deworming interventions.
Topics: Albendazole; Anemia; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Child, Preschool; Die | 2004 |
Periodic deworming with albendazole and its impact on growth status and diarrhoeal incidence among children in an urban slum of India.
Topics: Albendazole; Anthelmintics; Child Development; Child, Preschool; Diarrhea; Double-Blind Method; Fema | 2005 |
Efficacy of benzimidazole carbamate on an intestinal fluke co-infected with nematodes.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Helminthiasis; Humans; Intestinal Diseases, Parasitic; M | 2005 |
Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
Topics: Adolescent; Adult; Albendazole; Animals; Ascariasis; Ascaris; Elephantiasis, Filarial; Female; Filar | 2005 |
[Effect of a novel drug--enteric coated tribendimidine in the treatment of intestinal nematode infections].
Topics: Adolescent; Adult; Aged; Albendazole; Ancylostomatoidea; Animals; Ascariasis; Ascaris lumbricoides; | 2006 |
Effects of deworming on malnourished preschool children in India: an open-labelled, cluster-randomized trial.
Topics: Albendazole; Anthelmintics; Body Height; Body Weight; Child Nutrition Disorders; Child, Preschool; F | 2008 |
A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China.
Topics: Administration, Oral; Adolescent; Adult; Aged; Albendazole; Animals; Antinematodal Agents; Ascariasi | 2008 |
New trend in the treatment of intestinal helminthiasis.
Topics: Adult; Africa, Western; Albendazole; Benzimidazoles; Child; Clinical Trials as Topic; Dose-Response | 1983 |
Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis.
Topics: Adolescent; Adult; Aged; Albendazole; Ancylostomiasis; Anthelmintics; Ascariasis; Benzimidazoles; Ch | 1983 |
Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Cestode Infections; Clinical Tr | 1984 |
Intestinal helminths. Anthelmintic drug trial.
Topics: Albendazole; Child; Follow-Up Studies; Helminthiasis; Humans; Intestinal Diseases; Intestinal Diseas | 1995 |
[Studies on the efficacy of albendazole candy for treatment of intestinal nematode infections].
Topics: Albendazole; Animals; Ascariasis; Child; Child, Preschool; Enterobiasis; Humans; Intestinal Diseases | 1994 |
Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Albendazole; Chronic Disease; Di | 1994 |
Comparative efficacy of three anthelmintics against mixed gastrointestinal nematode infections in camels.
Topics: Albendazole; Analysis of Variance; Animals; Anthelmintics; Camelus; Feces; Female; Intestinal Diseas | 1997 |
Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren.
Topics: Administration, Oral; Albendazole; Anthelmintics; Antitrichomonal Agents; Child; Feces; Humans; Inte | 1997 |
Comparative efficacy of pyrethrum marc with albendazole against sheep gastrointestinal nematodes.
Topics: Albendazole; Animals; Anthelmintics; Chrysanthemum cinerariifolium; Cross-Over Studies; Feces; Femal | 1998 |
A study of the cost effectiveness of selective health interventions for the control of intestinal parasites in rural Bangladesh.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Bangladesh; Child; Child, Preschool; Cost-Benefit A | 1999 |
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Body Height; Child; Child, Preschool; Double-Blind | 1999 |
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Body Height; Child; Child, Preschool; Double-Blind | 1999 |
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Body Height; Child; Child, Preschool; Double-Blind | 1999 |
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Body Height; Child; Child, Preschool; Double-Blind | 1999 |
Anthelminthic treatment and haemoglobin concentrations during pregnancy.
Topics: Adolescent; Adult; Albendazole; Anemia; Anthelmintics; Dietary Supplements; Female; Folic Acid; Helm | 2000 |
A comparative study of different albendazole and mebendazole regimens for the treatment of intestinal infections in school children of Usigu Division, western Kenya.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Drug Administration Schedule | 2001 |
[Field trials on the efficacy of albendazole composite against intestinal nematodiasis].
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antinematodal Agents; Ascaris; Child; Child, Preschoo | 1998 |
Overberg research projects. XII. The efficacy of an albendazole slow-release capsule in the control of nematode parasites of sheep.
Topics: Albendazole; Animals; Capsules; Delayed-Action Preparations; Female; Intestinal Diseases, Parasitic; | 1992 |
The efficacy of an albendazole intraruminal controlled-release device against gastrointestinal parasitism in lambs.
Topics: Abomasum; Albendazole; Animals; Body Weight; Delayed-Action Preparations; Feces; Intestinal Diseases | 1992 |
The efficacy of treatment with albendazole.
Topics: Adolescent; Adult; Albendazole; Ascariasis; Child; Female; Hookworm Infections; Humans; Intestinal D | 1991 |
[Clinical trial of the treatment of various nematode infections of the digestive tract with albendazole].
Topics: Albendazole; Ancylostomiasis; Ascariasis; Benzimidazoles; Clinical Trials as Topic; Humans; Intestin | 1988 |
Albendazole, a broad-spectrum anthelmintic, in the treatment of intestinal nematode and cestode infection: a multicenter study in 480 patients.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Benzimidazoles; Cestode Infections; Child; Child, Pre | 1986 |
131 other studies available for albendazole and Intestinal Diseases, Parasitic
| Article | Year |
|---|---|
Synthesis and antitrichinellosis activity of some bis(benzimidazol-2-yl)amines.
Topics: Amines; Animals; Anthelmintics; Benzimidazoles; Cell Survival; Dose-Response Relationship, Drug; Int | 2007 |
Assessment of the potential prophylactic and therapeutic effects of kaempferol on experimental
Topics: Albendazole; Animals; Anthelmintics; Intestinal Diseases, Parasitic; Kaempferols; Male; Mice; Trichi | 2023 |
Changes in the epidemiological profile of intestinal parasites after a school-based large-scale treatment for soil-transmitted helminths in a community in northeastern Brazil: Epidemiological profile after large-scale school-based treatment for STH.
Topics: Albendazole; Animals; Brazil; Chemoprevention; Child; Female; Helminthiasis; Humans; Intestinal Dise | 2020 |
Quality of anthelminthic medicines available in Jimma Ethiopia.
Topics: Albendazole; Anthelmintics; Ethiopia; Helminthiasis; Humans; Intestinal Diseases, Parasitic; Mebenda | 2018 |
The effectiveness of empirical anti-parasitic treatment in returning travellers with persistent abdominal symptoms.
Topics: Administration, Oral; Adolescent; Adult; Aged; Albendazole; Anthelmintics; Diarrhea; Drug Administra | 2018 |
Association between gastrointestinal tract infections and glycated hemoglobin in school children of poor neighborhoods in Port Elizabeth, South Africa.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Cross-Sectional Studies; Feces; Female; Gast | 2018 |
Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Burundi; Case Management; Child; Endemic Dis | 2018 |
Laryngeal spasm after general anaesthesia due to Ascaris lumbricoides.
Topics: Afghanistan; Albendazole; Anesthesia Recovery Period; Anesthesia, General; Animals; Anthelmintics; A | 2013 |
Factors associated with parasitic infection amongst street children in orphanages across Lima, Peru.
Topics: Age Distribution; Albendazole; Anthelmintics; Body Mass Index; Child; Cross-Sectional Studies; Entam | 2013 |
Control of soil-transmitted helminthiasis in Myanmar: results of 7 years of deworming.
Topics: Albendazole; Anemia; Anthelmintics; Child; Child, Preschool; Feces; Government Programs; Helminthias | 2013 |
Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Antibodies, Helmint | 2013 |
Gastrointestinal: Strongyloides stercoralis infestation.
Topics: Albendazole; Animals; Anthelmintics; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Disease | 2014 |
Intestinal capillariasis in the 21st century: clinical presentations and role of endoscopy and imaging.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Capillaria; Capsule En | 2014 |
Evidence to implementation continuum for universal health coverage.
Topics: Albendazole; Animals; Anthelmintics; Female; Helminthiasis; Humans; Intestinal Diseases, Parasitic; | 2015 |
Prevalence of intestinal helminths, anemia, and malnutrition in Paucartambo, Peru.
Topics: Albendazole; Anemia; Anthelmintics; Child; Child, Preschool; Cross-Sectional Studies; Educational St | 2015 |
Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole.
Topics: Albendazole; Animals; Child; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filari | 2015 |
[Malignant anguillulosis of fatal outcome in pemphigus vegetans].
Topics: Adult; Albendazole; Animals; Anthelmintics; Colistin; Eosinophilia; Fatal Outcome; Female; Hemoptysi | 2015 |
Prevalence of Schistosomes and Soil-Transmitted Helminths among Schoolchildren in Lake Victoria Basin, Tanzania.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Feces; Female; Helminthiasis; Helminths; Hum | 2015 |
Prevalence of Schistosomes and Soil-Transmitted Helminths and Morbidity Associated with Schistosomiasis among Adult Population in Lake Victoria Basin, Tanzania.
Topics: Adult; Albendazole; Animals; Anthelmintics; Feces; Female; Helminthiasis; Helminths; Humans; Intesti | 2015 |
Hookworm infestation is not an uncommon cause of obscure occult and overt gastrointestinal bleeding in an endemic area: A study using capsule endoscopy.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Anthelmintics; Capsule Endoscopy; Female; Follow-Up Stu | 2015 |
Helminthiasis: Hookworm Infection Remains a Public Health Problem in Dera District, South Gondar, Ethiopia.
Topics: Adolescent; Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Child; Child, Preschool; | 2015 |
Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Antiprotozoal Agent | 2016 |
Anthelmintic resistance in gastrointestinal nematodes of beef cattle in the state of Rio Grande do Sul, Brazil.
Topics: Albendazole; Animals; Animals, Domestic; Antinematodal Agents; Brazil; Cattle; Cattle Diseases; Drug | 2016 |
Woman With Dyspnea and Abdominal Rash.
Topics: Abdominal Pain; Albendazole; Antiparasitic Agents; Black People; Dyspnea; Endoscopy, Digestive Syste | 2016 |
[Case report: strongyloidiosis with chronic abdominal pain].
Topics: Abdominal Pain; Albendazole; Animals; Anthelmintics; Child; Chronic Disease; Diagnosis, Differential | 2008 |
The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania.
Topics: Albendazole; Animals; Anthelmintics; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Fema | 2009 |
Prevalence and risk factors associated with worm infestation in pre-school children (6-23 months) in selected blocks of Uttar Pradesh and Jharkhand, India.
Topics: Albendazole; Anthelmintics; Confidence Intervals; Cross-Sectional Studies; Female; Helminthiasis; Hu | 2008 |
[Appendicitis in an HIV-positive South American immigrant].
Topics: Abdominal Abscess; Albendazole; Animals; Anthelmintics; Anti-HIV Agents; Appendectomy; Appendicitis; | 2010 |
An unusual cause of rectal bleeding: intestinal myiasis.
Topics: Albendazole; Anthelmintics; Antinematodal Agents; Cathartics; Child; Diagnosis, Differential; Female | 2010 |
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report.
Topics: Aged; Albendazole; Animals; Antinematodal Agents; Arthritis, Rheumatoid; Asthma; Drug Therapy, Combi | 2010 |
Albendazole failure to control resistant nematodes in lambs: lack of effect of fasting-induced improvement on drug absorption.
Topics: Absorption; Albendazole; Animals; Anthelmintics; Biological Availability; Fasting; Feces; Intestinal | 2010 |
Effectiveness of a school-based deworming campaign in rural Kenya.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Cross-Sectional Studies; Drug Administration Schedule | 2011 |
Prevalence and chemo-therapeutical investigations of gastrointestinal nematodes in domestic pigeons in Lahore, Pakistan.
Topics: Albendazole; Animals; Anthelmintics; Ascaridia; Capillaria; Columbidae; Feces; Female; Fenbendazole; | 2011 |
Ascaris lumbricoides causing infarction of the mesenteric lymph nodes and intestinal gangrene in a child: a case report.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Child, Preschool; Female; Gan | 2011 |
A truly emerging intestinal parasitosis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Female; Humans; Intest | 2011 |
Capillaria philippinensis in Upper Egypt: has it become endemic?
Topics: Adult; Albendazole; Animals; Anthelmintics; Capillaria; Child; Egypt; Endemic Diseases; Enoplida Inf | 2012 |
Overt gastrointestinal bleeding because of hookworm infection.
Topics: Albendazole; Anthelmintics; Capsule Endoscopy; Gastrointestinal Hemorrhage; Hookworm Infections; Hum | 2012 |
Albendazole therapy and enteric parasites in United States-bound refugees.
Topics: Adolescent; Adult; Africa; Albendazole; Animals; Antiparasitic Agents; Asia, Southeastern; Child; Ch | 2012 |
An indigenous case of intestinal capillariasis with protein-losing enteropathy in Korea.
Topics: Adult; Albendazole; Animals; Anthelmintics; Biopsy; Capillaria; Diarrhea; Enoplida Infections; Feces | 2012 |
Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Drug Therapy | 2012 |
National intestinal helminth survey among schoolchildren in Tajikistan: prevalences, risk factors and perceptions.
Topics: Adult; Albendazole; Animals; Anthelmintics; Child; Cohort Studies; Cross-Sectional Studies; Data Col | 2013 |
Intestinal helminthiases and their control with albendazole among primary schoolchildren in riverine communities of Ondo State, Nigeria.
Topics: Adolescent; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascaris lumbricoides; Child; Chi | 2002 |
A survey on the occurrence of resistance to anthelmintics of gastrointestinal nematodes of goats in Mozambique.
Topics: Albendazole; Animals; Anthelmintics; Drug Resistance; Feces; Fenbendazole; Goat Diseases; Goats; Int | 2002 |
Strategic control of gastrointestinal nematodes of sheep in the highlands of central Kenya.
Topics: Albendazole; Animals; Anthelmintics; Feces; Intestinal Diseases, Parasitic; Kenya; Nematoda; Nematod | 2002 |
[Thirty-two-year-old male patient with recurrent abdominal pain and slight amylase elevation].
Topics: Abdominal Pain; Adult; Albendazole; Amylases; Animals; Anthelmintics; Bile Duct Diseases; Biomarkers | 2002 |
[Longitudinal observation on the control of intestinal helminthiasis].
Topics: Albendazole; Anthelmintics; China; Health Education; Humans; Intestinal Diseases, Parasitic; Longitu | 2000 |
[Target chemotherapy of intestinal nematode infection in area with low endemicity].
Topics: Adult; Aged; Albendazole; Antinematodal Agents; Drug Therapy, Combination; Evaluation Studies as Top | 2002 |
Albendazole resistance in gastrointestinal nematode parasites of cattle in Bangladesh.
Topics: Albendazole; Animals; Anthelmintics; Bangladesh; Cattle; Cattle Diseases; Drug Resistance; Feces; Fe | 2003 |
Evaluation of prevalence and clinical implications of anthelmintic resistance in gastrointestinal nematodes in goats.
Topics: Albendazole; Animals; Anthelmintics; Drug Resistance; Feces; Female; Georgia; Goat Diseases; Goats; | 2003 |
Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas pre-departure treatment program.
Topics: Adolescent; Adult; Africa; Aged; Aged, 80 and over; Albendazole; Child; Child, Preschool; Communicab | 2003 |
Clinical features of human intestinal capillariasis in Taiwan.
Topics: Adult; Aged; Albendazole; Animals; Anthelmintics; Capillaria; Enoplida Infections; Feces; Female; Hu | 2004 |
Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
Topics: Adolescent; Adult; Age Distribution; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; D | 2004 |
Cure and reinfection patterns of geohelminthic infections after treatment in communities inhabiting the tropical rainforest of Assam, India.
Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascari | 2004 |
Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Topics: Albendazole; Animals; Anthelmintics; Drug Therapy, Combination; Feces; Female; Humans; Intestinal Di | 2004 |
[The (children's) parasitic worms].
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Child; Enterobiasis; Enterobius; Female; | 2004 |
Microsporidiosis in travel-associated chronic diarrhea in immune-competent patients.
Topics: Adolescent; Adult; Albendazole; Animals; Antiprotozoal Agents; Chronic Disease; Diarrhea; Encephalit | 2005 |
Intestinal helminth infection in an ethnic minority commune in southern Vietnam.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Communicable Disease Contr | 2005 |
Partial small bowel obstruction in a traveler.
Topics: Albendazole; Anthelmintics; Ascariasis; Female; Humans; Intestinal Diseases, Parasitic; Intestinal O | 2006 |
[Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Combined Modality Therapy; Confusion; Cysticercosis; | 2004 |
HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi.
Topics: Adult; Albendazole; Ambulatory Care; Anthelmintics; Antiprotozoal Agents; CD4 Lymphocyte Count; Fece | 2007 |
The endoscopic-pathologic findings in intestinal capillariais: a case report.
Topics: Adult; Albendazole; Animals; Anthelmintics; Capillaria; Endoscopy, Gastrointestinal; Enoplida Infect | 2007 |
Using national health weeks to deliver deworming to children: lessons from Mexico.
Topics: Adolescent; Age Distribution; Albendazole; Anthelmintics; Ascariasis; Child; Child, Preschool; Deliv | 2008 |
[Albendazole in the treatment of simultaneous infection by Trichuris trichiura and other intestinal helminths in children].
Topics: Adolescent; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Drug Evaluation; Fe | 1984 |
[Effect of albendazole in the treatment of 269 cases of intestinal nematode infection].
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Humans; Inte | 1984 |
[Albendazole in the treatment of common intestinal parasite infections among school children in Taiwan].
Topics: Albendazole; Anthelmintics; Benzimidazoles; Child; Humans; Intestinal Diseases, Parasitic; Nematode | 1984 |
Study of albendazole in the treatment of intestinal helminthiasis in Zimbabwe.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Female; Helm | 1983 |
Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Duodenum; Feces; | 1995 |
Capillariasis with chronic intestinal pseudo-obstruction.
Topics: Adult; Albendazole; Animals; Capillaria; Chronic Disease; Enoplida Infections; Humans; Intestinal Di | 1994 |
Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Diarrhea; Duodenum; Feces; Human | 1995 |
Albendazole: new hope for treatment of microsporidiosis in AIDS.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Diarrhea; Humans; Intestinal Diseases, | 1995 |
Efficacy of common broad spectrum anthelmintics against hook worm, Ascaris and Trichiuris in Hat Yai district, Songkhla Province, Thailand.
Topics: Albendazole; Anthelmintics; Ascariasis; Child; Hookworm Infections; Humans; Intestinal Diseases, Par | 1994 |
[Effect of combined chemotherapy against human intestinal nematode eggs].
Topics: Adolescent; Adult; Albendazole; Ancylostomiasis; Ascariasis; Child; Child, Preschool; Drug Combinati | 1994 |
[Effect of bolus administration of albendazole into the rumen on gastrointestinal nematodes and the Dicrocoelium dendriticum trematode in sheep].
Topics: Albendazole; Animals; Capsules; Dicrocoeliasis; Dicrocoelium; Digestive System; Female; Intestinal D | 1994 |
Multiple anthelmintic resistance of nematodes in imported goats.
Topics: Albendazole; Animals; Anthelmintics; Drug Resistance; Feces; Goat Diseases; Goats; Intestinal Diseas | 1993 |
Treatment and control of the intestinal fluke, Skrjabinotrema ovis.
Topics: Albendazole; Animals; Antiplatyhelmintic Agents; Benzimidazoles; China; Feces; Female; Intestinal Di | 1993 |
Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole.
Topics: Albendazole; Animals; Diarrhea; Humans; Intestinal Diseases, Parasitic; Microscopy, Electron; Micros | 1993 |
Microsporidiosis in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Feces; Humans; Intestinal Diseases, Paras | 1993 |
The pattern of faecal egg output in lambs infected with a multiple resistant strain of Haemonchus contortus after treatment with albendazole.
Topics: Albendazole; Animals; Drug Resistance; Feces; Haemonchiasis; Haemonchus; Intestinal Diseases, Parasi | 1993 |
More nutrients, fewer parasites, better learning.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Child Nutritional Physiological Phenomena; Female; Hu | 1996 |
[Recurrent dyspnea attacks, urticaria, epigastric symptoms and eosinophilia].
Topics: Adult; Albendazole; Anthelmintics; Dyspepsia; Dyspnea; Eosinophilia; Feces; Female; Humans; Intestin | 1997 |
[Control of gastrointestinal helminthiasis in pasture-reared lambs].
Topics: Albendazole; Animal Husbandry; Animals; Anthelmintics; Female; Helminthiasis; Helminthiasis, Animal; | 1997 |
Intestinal strongyloidiasis--a rare opportunistic infection.
Topics: Adult; Albendazole; Animals; Anthelmintics; Diarrhea; Fatal Outcome; Female; Humans; Immunosuppressi | 1997 |
A patient with acquired immunodeficiency syndrome and untreated Encephalitozoon (Septata) intestinalis microsporidiosis leading to small bowel perforation. Response to albendazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Encephalitozoon; | 1997 |
Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
Topics: Albendazole; Animals; Anthelmintics; Female; Intestinal Diseases, Parasitic; Mice; Muscles; Trichine | 1997 |
The strategic use of closantel and albendazole in controlling naturally acquired gastrointestinal nematodes of sheep in the Kenya highlands.
Topics: Albendazole; Analysis of Variance; Animals; Anthelmintics; Digestive System; Feces; Female; Haemonch | 1997 |
[Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma].
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Duodenum; Feces; Germany | 1998 |
Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Feces; Hum | 1998 |
Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Drug Combi | 1998 |
The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants.
Topics: Albendazole; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Emigra | 1999 |
Encephalitozoon intestinale infection in an AIDS patient--a case report.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Antiprotozoal Agents; Autopsy; Cause of Death; C | 1999 |
Efficacy of closantel plus albendazole liquid suspension against natural infection of gastrointestinal parasites in camels.
Topics: Albendazole; Animals; Anthelmintics; Camelus; Drug Combinations; Feces; Female; Helminthiasis, Anima | 1999 |
A case of Strongyloides stercoralis infection.
Topics: Albendazole; Animals; Anthelmintics; Feces; Female; Humans; Intestinal Diseases, Parasitic; Larva; M | 1999 |
The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development.
Topics: Albendazole; Anthelmintics; Child; Costs and Cost Analysis; Ghana; Humans; Intestinal Diseases, Para | 1999 |
Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis.
Topics: Aged; Albendazole; Alleles; Animals; Anthelmintics; Antibodies, Helminth; Drug Resistance; Enzyme-Li | 1999 |
Efficacy of various chemotherapeutic agents on the growth of Spironucleus vortens, an intestinal parasite of the freshwater angelfish.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Count; Dimetridazole; Diplomonadida; Fenbendazole; | 1999 |
Enterobius vermicularis egg positive rate in a primary school in Chungchongnam-do (province) in Korea.
Topics: Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Enterobiasis; Enterobius; Humans; Inte | 2000 |
Don't get caught with your pants down.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Anthelmintics; Humans; Intestinal Diseases, Para | 1996 |
Enterobius vermicularis egg positive rates in primary school children in Gangwon-do (province), Korea.
Topics: Age Factors; Albendazole; Child; Enterobiasis; Female; Humans; Intestinal Diseases, Parasitic; Korea | 2001 |
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Topics: Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Feces; Female; Gene Expression Regu | 2002 |
Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Anti-Bacterial Agents; Antiprotozoal Agents; Azi | 2001 |
Efficacy of albendazole against Trichinella pseudospiralis and Trichinella spiralis in mice.
Topics: Albendazole; Animals; Intestinal Diseases, Parasitic; Male; Mice; Mice, Inbred Strains; Muscles; Tri | 1992 |
The effect of repeated chemotherapy on the prevalence and intensity of Ascaris lumbricoides and Trichuris trichiura infection.
Topics: Adolescent; Adult; Age Factors; Albendazole; Animals; Ascariasis; Ascaris lumbricoides; Child; Femal | 1992 |
Controlled-release anthelmintic treatment of milking goats.
Topics: Albendazole; Animals; Delayed-Action Preparations; Feces; Female; Goat Diseases; Goats; Intestinal D | 1992 |
Use of a controlled-release albendazole capsule in goats.
Topics: Albendazole; Animals; Capsules; Delayed-Action Preparations; Feces; Female; Goat Diseases; Goats; In | 1992 |
[Strongyloidiasis under immunosuppressive therapy].
Topics: Albendazole; Autoimmune Diseases; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intes | 1992 |
Intestinal capillariasis (Capillaria philippinensis) acquired in Indonesia: a case report.
Topics: Adult; Albendazole; Animals; Capillaria; Feces; Humans; Indonesia; Intestinal Diseases, Parasitic; I | 1992 |
Efficacy of albendazole, levamisole and fenbendazole against gastrointestinal nematodes of cattle, with emphasis on inhibited early fourth stage Ostertagia ostertagi larvae.
Topics: Abomasum; Albendazole; Animals; Benzimidazoles; Body Weight; Cattle; Cattle Diseases; Feces; Female; | 1991 |
Overberg research projects. XIII. A comparison of the efficacy of albendazole drench and an albendazole slow-release capsule against nematode parasites in sheep.
Topics: Albendazole; Animals; Capsules; Delayed-Action Preparations; Intestinal Diseases, Parasitic; Male; N | 1991 |
Gastrointestinal helminthosis in fallow deer (Dama dama) and their response to treatment with anthelmintics.
Topics: Albendazole; Animals; Anthelmintics; Deer; Feces; Helminthiasis; Helminthiasis, Animal; Intestinal D | 1991 |
[Use of an albendazole bolus against gastrointestinal nematode infections in first year cattle].
Topics: Albendazole; Animals; Cattle; Cattle Diseases; Female; Intestinal Diseases, Parasitic; Nematode Infe | 1991 |
Internal parasite levels and response to anthelmintic treatment by beef cows and calves.
Topics: Age Factors; Albendazole; Animals; Cattle; Cattle Diseases; Cestode Infections; Coccidiosis; Feces; | 1991 |
The efficacy of a controlled-release albendazole capsule in suppressing nematode burdens in sheep.
Topics: Albendazole; Animals; Body Weight; Capsules; Delayed-Action Preparations; Drug Resistance; Feces; In | 1990 |
Evaluation of the treatment of intestinal helminthiases with albendazole in Djohong (North Cameroon).
Topics: Adolescent; Adult; Aged; Albendazole; Cameroon; Child; Child, Preschool; Feces; Female; Helminthiasi | 1990 |
Mebendazole and albendazole for infants.
Topics: Albendazole; Humans; Infant; Intestinal Diseases, Parasitic; Mebendazole | 1990 |
Effect of nematode infections on growth performance of calves during winter housing on dairy farms.
Topics: Albendazole; Animals; Cattle; Cattle Diseases; Feces; Housing, Animal; Intestinal Diseases, Parasiti | 1990 |
Efficacy of three broad-spectrum anthelmintics against gastrointestinal nematode infections of goats.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Brazil; Goat Diseases; Goats; Intestinal Diseas | 1989 |
Detecting benzimidazole resistance with faecal egg count reduction tests and in vitro assays.
Topics: Albendazole; Analysis of Variance; Animals; Anthelmintics; Benzimidazoles; Drug Resistance; Feces; I | 1989 |
Longitudinal study on the health status of children in a rural Tanzanian community: parasitoses and nutrition following control measures against intestinal parasites.
Topics: Adolescent; Age Factors; Albendazole; Anthelmintics; Benzimidazoles; Child; Child Nutritional Physio | 1987 |
'Albendazole' in intestinal helminthiasis.
Topics: Adolescent; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Female; Helminthias | 1986 |
Field evaluation of an experimental albendazole pulse release bolus in the control of parasitic gastroenteritis in first-season grazing calves.
Topics: Albendazole; Animals; Benzimidazoles; Cattle; Cattle Diseases; Feces; Female; Gastroenteritis; Intes | 1988 |
Albendazole in the treatment of intestinal capillariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Benzimidazoles; Capillaria; Child; Feces; Fe | 1987 |
The treatment of intestinal helminthiasis with albendazole.
Topics: Adolescent; Adult; Albendazole; Benzimidazoles; Child; Helminthiasis; Humans; Intestinal Diseases, P | 1987 |
Effect of albendazole on enteral and parenteral phases of Trichinella spiralis.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Intestinal Diseases, Parasitic; Larva; Male; Mi | 1987 |
Albendazole (Zentel) in the treatment of helminthiasis in children below two years of age: a preliminary report.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Female; Helminthiasis; Humans; Infant; Intestinal Diseas | 1987 |
[Comparison of albendazole and pyrantel pamoate in the treatment of intestinal nematode infections].
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Female; Humans; Intestinal Dise | 1986 |
Albendazole: a new broad spectrum anthelmintic for treatment of intestinal helminthiasis.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Benzimidazoles; Child; Female; Helminthiasis; Humans; | 1986 |
Comparison of two control systems for cyathostome infections in the horse and further aspects of the epidemiology of these infections.
Topics: Albendazole; Animals; Antinematodal Agents; Benzimidazoles; Female; Horse Diseases; Horses; Intestin | 1986 |
Efficacy of an albendazole feed formulation against bovine gastrointestinal nematodes including arrested larvae of Ostertagia ostertagi.
Topics: Albendazole; Animal Feed; Animals; Anthelmintics; Benzimidazoles; Cattle; Cattle Diseases; Feces; Ha | 1986 |
Albendazole in the treatment of intestinal helminthiasis in children.
Topics: Adolescent; Albendazole; Ancylostomiasis; Anthelmintics; Ascariasis; Benzimidazoles; Child; Child, P | 1985 |
[Albendazole in the treatment of intestinal nematode infections in Kinshasa, Zaire].
Topics: Adolescent; Adult; Aged; Albendazole; Antinematodal Agents; Benzimidazoles; Child; Child, Preschool; | 1985 |
Albendazole in the treatment of intestinal helminthiasis in children.
Topics: Albendazole; Ancylostomiasis; Anthelmintics; Ascariasis; Benzimidazoles; Child; Child, Preschool; Dr | 1985 |